US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Impact Biomedical, Inc.

0.6453

-0.1347-17.27%

Volume:854.84K

Turnover:539.08K

Market Cap:69.69M

PE:-1.70

High:0.6940

Open:0.5801

Low:0.5751

Close:0.7800

52wk High:4.50

52wk Low:0.3621

Shares:108.00M

Float Shares:11.64M

Volume Ratio:0.83

T/O Rate:7.35%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3800

EPS(LYR):-0.3800

ROE:-104.16%

ROA:-14.16%

PB:5.53

PE(LYR):-1.70

Loading ...

Overview Company News Filings

Impact Biomedical FY 2025 net loss narrows 52% to USD 11.87 million as professional fees more than doubled to USD 1.01 million

Why Is Impact BioMedical Stock (IBO) Up Today?

Impact Biomedical (IBO) Stock Jumps Over 86% After Hours — Here's Why

Benzinga_recent_news

Impact BioMedical Amends Merger Terms and Extends Deadline

Impact BioMedical Extends Dr Ashleys Merger Deadline to July 1, 2026

Universal Ibogaine Ties Delayed Audit to Restructuring and Planned Sale of Kelburn Facility

DSS, Inc. Reports Disposal of Impact Biomedical Inc. Common Shares

Impact Biomedical Inc. Files Information Statement Outlining Authorized Corporate Actions

Impact Biomedical Inc. Files Preliminary Information Statement Outlining Authorized Corporate Actions

Universal Ibogaine Seeks Cease Trade Order Amid Financial Filing Delays

Impact Biomedical Inc. held annual shareholder meeting

Impact BioMedical Converts Preferred Stock to Common

Universal Ibogaine Restructures Board Ahead of Clinical Trial Submission

Impact Biomedical Inc. Announces Date for 2025 Annual Stockholders Meeting

Universal Ibogaine Announces Key Outcomes from Annual Shareholder Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IBO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBO\",,,,,undefined,":{"symbol":"IBO","market":"US","secType":"STK","nameCN":"Impact Biomedical, Inc.","latestPrice":0.6453,"timestamp":1774286369609,"preClose":0.78,"halted":0,"volume":854838,"delay":0,"changeRate":-0.17269230769230773,"floatShares":11638100,"shares":108000000,"eps":-0.38,"marketStatus":"Trading","change":-0.1347,"latestTime":"03-23 13:25:39 EDT","open":0.5801,"high":0.694,"low":0.5751,"amount":539082.1282662001,"amplitude":0.152436,"askPrice":0.6453,"askSize":100,"bidPrice":0.6292,"bidSize":57,"shortable":0,"etf":0,"ttmEps":-0.38,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1774296000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1721361600000,"exchange":"AMEX","adjPreClose":0.78,"preHourTrading":{"tag":"盘前","latestPrice":0.5773,"preClose":0.78,"latestTime":"09:28 EDT","volume":122121,"amount":72243.44969669999,"timestamp":1774272522731,"change":-0.2027,"changeRate":-0.259872,"amplitude":0.126154},"postHourTrading":{"tag":"盘后","latestPrice":0.6347,"preClose":0.78,"latestTime":"19:59 EDT","volume":3231231,"amount":2067969.783277,"timestamp":1774051189498,"change":-0.1453,"changeRate":-0.186282,"amplitude":0.306923},"volumeRatio":0.825155,"impliedVol":0.2695,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBO\",,,,,undefined,":{"symbol":"IBO","floatShares":11638100,"roa":"-14.16%","roe":"-104.16%","lyrEps":-0.38,"volumeRatio":0.825155,"shares":108000000,"dividePrice":0,"high":0.694,"amplitude":0.152436,"preClose":0.78,"low":0.5751,"week52Low":0.3621,"pbRate":"5.53","psRate":"2177.89","week52High":4.5,"institutionHeld":0,"latestPrice":0.6453,"committee":-0.273885,"eps":-0.38,"divideRate":0,"volume":854838,"delay":0,"ttmEps":-0.38,"open":0.5801,"prevYearClose":0.505,"prevWeekClose":0.78,"prevMonthClose":0.4353,"prevQuarterClose":0.505,"fiveDayClose":0.4388,"twentyDayClose":0.4418,"sixtyDayClose":0.5617},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBO\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IBO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IBO","date":"2026-03-20","current":-2.052632,"percent":0.079787,"low":-7.852882,"twenty":-1.160064,"median":-0.258203,"eighty":14.218296,"high":48.978211,"avg":3.54224,"sd":9.456975,"marketCap":49921229},"quantilePoints":[{"date":"2024-09-20","current":-6.823884,"twenty":-6.997189,"median":-6.647871,"eighty":-6.406869,"marketCap":28974211},{"date":"2024-09-27","current":-6.471858,"twenty":-6.910536,"median":-6.471858,"eighty":-6.309385,"marketCap":27479510},{"date":"2024-10-04","current":-4.468019,"twenty":-6.775142,"median":-6.309385,"eighty":-5.239768,"marketCap":18971209},{"date":"2024-10-11","current":-4.260324,"twenty":-6.580174,"median":-5.415781,"eighty":-4.180929,"marketCap":18089336},{"date":"2024-10-18","current":-3.864701,"twenty":-6.471858,"median":-5.077294,"eighty":-4.002262,"marketCap":16409521},{"date":"2024-10-25","current":-4.738808,"twenty":-6.374374,"median":-4.468019,"eighty":-3.910194,"marketCap":20120980},{"date":"2024-10-31","current":-5.984438,"twenty":-6.309385,"median":-5.036676,"eighty":-3.937273,"marketCap":25409923},{"date":"2024-11-08","current":-7.552848,"twenty":-6.791389,"median":-5.368393,"eighty":-3.986015,"marketCap":32069393},{"date":"2024-11-15","current":24.785345,"twenty":-7.039432,"median":-5.415781,"eighty":-3.937273,"marketCap":28874927},{"date":"2024-11-22","current":25.871555,"twenty":-6.952238,"median":-5.077294,"eighty":-3.531089,"marketCap":30140362},{"date":"2024-11-29","current":28.833947,"twenty":-6.807637,"median":-4.603414,"eighty":19.151303,"marketCap":33591548},{"date":"2024-12-06","current":22.514178,"twenty":-6.688489,"median":-4.260324,"eighty":24.785345,"marketCap":26229017},{"date":"2024-12-13","current":21.230475,"twenty":-6.471858,"median":-4.053712,"eighty":24.548354,"marketCap":24733503},{"date":"2024-12-20","current":16.490647,"twenty":-6.439363,"median":-3.95352,"eighty":23.560889,"marketCap":19211604},{"date":"2024-12-27","current":15.799423,"twenty":-6.309385,"median":-3.885823,"eighty":23.402895,"marketCap":18406328},{"date":"2025-01-03","current":15.206944,"twenty":-6.309385,"median":-3.628573,"eighty":23.007909,"marketCap":17716090},{"date":"2025-01-10","current":17.774351,"twenty":-6.27689,"median":-3.439292,"eighty":22.790667,"marketCap":20707119},{"date":"2025-01-17","current":15.898169,"twenty":-6.092754,"median":12.787657,"eighty":22.593175,"marketCap":18521367},{"date":"2025-01-24","current":15.503184,"twenty":-5.93028,"median":14.167144,"eighty":22.435181,"marketCap":18061209},{"date":"2025-01-31","current":18.308568,"twenty":-5.773222,"median":14.515719,"eighty":22.000696,"marketCap":21329482},{"date":"2025-02-07","current":18.663068,"twenty":-5.562007,"median":14.960078,"eighty":21.408218,"marketCap":21742474},{"date":"2025-02-14","current":21.230475,"twenty":-5.415781,"median":15.40345,"eighty":21.8822,"marketCap":24733503},{"date":"2025-02-21","current":19.749279,"twenty":-5.396826,"median":15.503184,"eighty":21.526713,"marketCap":23007910},{"date":"2025-02-28","current":15.206944,"twenty":-5.280387,"median":15.799423,"eighty":21.467465,"marketCap":17716090},{"date":"2025-03-07","current":11.948313,"twenty":-5.101666,"median":15.503184,"eighty":21.230475,"marketCap":13919785},{"date":"2025-03-14","current":6.617983,"twenty":-4.977102,"median":15.305197,"eighty":21.210726,"marketCap":7709950},{"date":"2025-03-21","current":20.53925,"twenty":-4.68465,"median":15.206944,"eighty":21.092229,"marketCap":23928226},{"date":"2025-03-28","current":22.514178,"twenty":-4.44094,"median":15.403944,"eighty":21.526713,"marketCap":26229017},{"date":"2025-04-04","current":-0.226956,"twenty":-4.318165,"median":15.206944,"eighty":21.467465,"marketCap":5607631},{"date":"2025-04-11","current":-0.249456,"twenty":-4.247705,"median":14.713213,"eighty":21.230475,"marketCap":6163560},{"date":"2025-04-17","current":-0.21375,"twenty":-4.19723,"median":14.416973,"eighty":21.230475,"marketCap":5281325},{"date":"2025-04-25","current":-0.20788,"twenty":-4.061836,"median":14.219481,"eighty":21.131728,"marketCap":5136300},{"date":"2025-05-02","current":-0.195652,"twenty":-4.045588,"median":14.120734,"eighty":20.934235,"marketCap":4834164},{"date":"2025-05-09","current":-0.243342,"twenty":-4.034757,"median":11.653062,"eighty":20.934235,"marketCap":6012492},{"date":"2025-05-16","current":-0.248299,"twenty":-3.95352,"median":8.822497,"eighty":20.931273,"marketCap":6210693},{"date":"2025-05-23","current":-0.265741,"twenty":-3.926441,"median":6.617983,"eighty":20.53925,"marketCap":6646976},{"date":"2025-05-30","current":-0.236751,"twenty":-3.893947,"median":6.024517,"eighty":20.53925,"marketCap":5921851},{"date":"2025-06-06","current":-0.240616,"twenty":-3.868925,"median":5.431051,"eighty":20.065268,"marketCap":6018535},{"date":"2025-06-13","current":-0.228296,"twenty":-3.675799,"median":-0.196924,"eighty":19.788778,"marketCap":5710357},{"date":"2025-06-20","current":-0.208921,"twenty":-3.531089,"median":-0.205288,"eighty":19.749279,"marketCap":5225732},{"date":"2025-06-27","current":-0.444512,"twenty":-3.450015,"median":-0.207718,"eighty":19.630783,"marketCap":11118579},{"date":"2025-07-03","current":-0.315507,"twenty":-3.41752,"median":-0.208564,"eighty":19.492537,"marketCap":7891774},{"date":"2025-07-11","current":-0.276757,"twenty":-2.342076,"median":-0.2115,"eighty":19.265421,"marketCap":6922523},{"date":"2025-07-18","current":-0.337104,"twenty":-0.74982,"median":-0.215206,"eighty":19.038305,"marketCap":8431991},{"date":"2025-07-25","current":-0.333674,"twenty":-0.612978,"median":-0.222159,"eighty":18.909935,"marketCap":8346185},{"date":"2025-08-01","current":-0.294972,"twenty":-0.468414,"median":-0.227287,"eighty":18.761815,"marketCap":7378144},{"date":"2025-08-08","current":-0.284053,"twenty":-0.45663,"median":-0.231823,"eighty":18.722316,"marketCap":7105013},{"date":"2025-08-15","current":-0.273955,"twenty":-0.436592,"median":-0.234874,"eighty":18.663068,"marketCap":6852428},{"date":"2025-08-22","current":-0.188262,"twenty":-0.41717,"median":-0.231823,"eighty":18.521268,"marketCap":7243008},{"date":"2025-08-29","current":-0.18606,"twenty":-0.405543,"median":-0.227287,"eighty":18.292374,"marketCap":7158283},{"date":"2025-09-05","current":-0.184588,"twenty":-0.400413,"median":-0.223319,"eighty":18.268082,"marketCap":7101658},{"date":"2025-09-12","current":-0.207551,"twenty":-0.378605,"median":-0.215733,"eighty":18.169336,"marketCap":7985100},{"date":"2025-09-19","current":-0.208501,"twenty":-0.365363,"median":-0.215554,"eighty":17.754602,"marketCap":8021656},{"date":"2025-09-26","current":-0.205207,"twenty":-0.359697,"median":-0.214679,"eighty":17.655855,"marketCap":7894928},{"date":"2025-10-03","current":-0.204162,"twenty":-0.344709,"median":-0.211774,"eighty":17.555134,"marketCap":7854716},{"date":"2025-10-10","current":-0.197922,"twenty":-0.342409,"median":-0.21056,"eighty":17.430516,"marketCap":7614663},{"date":"2025-10-17","current":-0.190511,"twenty":-0.339607,"median":-0.20889,"eighty":17.24033,"marketCap":7329525},{"date":"2025-10-24","current":-0.184968,"twenty":-0.338302,"median":-0.208343,"eighty":17.023878,"marketCap":7116280},{"date":"2025-10-31","current":-0.166598,"twenty":-0.336418,"median":-0.208076,"eighty":16.727639,"marketCap":6409526},{"date":"2025-11-07","current":-0.169068,"twenty":-0.333268,"median":-0.207551,"eighty":16.464578,"marketCap":6504572},{"date":"2025-11-14","current":-1.207414,"twenty":-0.342409,"median":-0.208076,"eighty":16.307374,"marketCap":53356827},{"date":"2025-11-21","current":-1.065365,"twenty":-0.378605,"median":-0.208343,"eighty":16.056163,"marketCap":47079553},{"date":"2025-11-28","current":-1.055895,"twenty":-0.424711,"median":-0.208858,"eighty":15.898169,"marketCap":46661069},{"date":"2025-12-05","current":-1.112715,"twenty":-0.707706,"median":-0.20991,"eighty":15.799423,"marketCap":49171978},{"date":"2025-12-12","current":-1.155566,"twenty":-1.035061,"median":-0.2115,"eighty":15.799423,"marketCap":51065622},{"date":"2025-12-19","current":-1.050687,"twenty":-1.044295,"median":-0.214215,"eighty":15.60193,"marketCap":46430902},{"date":"2025-12-26","current":-1.207651,"twenty":-1.055895,"median":-0.215041,"eighty":15.522933,"marketCap":53367289},{"date":"2026-01-02","current":-1.195576,"twenty":-1.0701,"median":-0.215838,"eighty":15.443936,"marketCap":52833721},{"date":"2026-01-09","current":-1.197944,"twenty":-1.090697,"median":-0.222159,"eighty":15.403845,"marketCap":52938342},{"date":"2026-01-16","current":-1.124315,"twenty":-1.139041,"median":-0.225853,"eighty":15.285546,"marketCap":49684622},{"date":"2026-01-23","current":-1.133904,"twenty":-1.140367,"median":-0.227957,"eighty":15.206944,"marketCap":50108338},{"date":"2026-01-30","current":-1.12692,"twenty":-1.135396,"median":-0.231919,"eighty":15.167446,"marketCap":49799705},{"date":"2026-02-06","current":-1.151068,"twenty":-1.149458,"median":-0.23584,"eighty":14.989702,"marketCap":50866842},{"date":"2026-02-13","current":-1.065365,"twenty":-1.147848,"median":-0.241583,"eighty":14.732962,"marketCap":47079553},{"date":"2026-02-20","current":-0.982503,"twenty":-1.145291,"median":-0.243342,"eighty":14.594717,"marketCap":43417810},{"date":"2026-02-27","current":-1.029853,"twenty":-1.141692,"median":-0.247381,"eighty":14.476221,"marketCap":45510235},{"date":"2026-03-06","current":-1.521105,"twenty":-1.141692,"median":-0.249456,"eighty":14.298478,"marketCap":67219140},{"date":"2026-03-13","current":-5.101425,"twenty":-1.150784,"median":-0.251559,"eighty":14.219481,"marketCap":60390671},{"date":"2026-03-20","current":-4.217032,"twenty":-1.160064,"median":-0.258203,"eighty":14.218296,"marketCap":49921229}],"updateTime":1774269500961},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618979343","title":"Impact Biomedical FY 2025 net loss narrows 52% to USD 11.87 million as professional fees more than doubled to USD 1.01 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2618979343","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618979343?lang=en_us&edition=fundamental","pubTime":"2026-03-12 05:32","pubTimestamp":1773264756,"startTime":"0","endTime":"0","summary":"Impact Biomedical FY 2025 net loss narrows 52% to USD 11.87 million as professional fees more than doubled to USD 1.01 million. Impact Biomedical reported a FY 2025 net loss of USD 11.87 million, narrowing 52% from the prior year. Total costs and expenses fell 85% to USD 4.31 million, reflecting the absence of a USD 25.09 million goodwill impairment recorded in FY 2024. The company recorded USD 32,000 of biotech retail sales from Celios air purification technology acquired in February 2025, while cost of revenue was USD 424,000 and included an impairment of about USD 419,000 of Celios inventory. Other expense was USD 10.17 million, compared with other income in the prior year, driven by a USD 9.39 million loss from changes in the fair value of a related-party note payable after a modification that allowed settlement in cash or shares. Impact Biomedical said it faces substantial doubt about its ability to continue as a going concern and is exploring capital raises and debt financing whi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL5p7xcW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","IBO","BK4024","AEI","BK4007"],"gpt_icon":0},{"id":"2617540568","title":"Why Is Impact BioMedical Stock (IBO) Up Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2617540568","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617540568?lang=en_us&edition=fundamental","pubTime":"2026-03-05 21:17","pubTimestamp":1772716647,"startTime":"0","endTime":"0","summary":"Impact BioMedical stock rallied after the company announced an amended merger agreement.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-impact-biomedical-stock-ibo-up-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-impact-biomedical-stock-ibo-up-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBO","BK4007"],"gpt_icon":0},{"id":"2617592759","title":"Impact Biomedical (IBO) Stock Jumps Over 86% After Hours — Here's Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2617592759","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617592759?lang=en_us&edition=fundamental","pubTime":"2026-03-05 12:38","pubTimestamp":1772685480,"startTime":"0","endTime":"0","summary":"Impact Biomedical shares jumped 86% after hours following amended merger terms with Dr Ashleys Bio Labs.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/04/Businessman-Interacting-With-Digital-For.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/04/Businessman-Interacting-With-Digital-For.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/26/03/51057591/impact-biomedical-ibo-stock-jumps-over-86-after-hours-heres-why","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/03/51057591/impact-biomedical-ibo-stock-jumps-over-86-after-hours-heres-why","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4007","IBO","BK4150","RSI"],"gpt_icon":0},{"id":"2617560998","title":"Impact BioMedical Amends Merger Terms and Extends Deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2617560998","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617560998?lang=en_us&edition=fundamental","pubTime":"2026-03-05 07:23","pubTimestamp":1772666607,"startTime":"0","endTime":"0","summary":"Impact BioMedical, Inc. ( ($IBO) ) has provided an announcement. On February 27, 2026, Impact BioMedical, Inc. and its transaction partners amended...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/impact-biomedical-amends-merger-terms-and-extends-deadline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/impact-biomedical-amends-merger-terms-and-extends-deadline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBO","BK4007"],"gpt_icon":0},{"id":"2617564826","title":"Impact BioMedical Extends Dr Ashleys Merger Deadline to July 1, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2617564826","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617564826?lang=en_us&edition=fundamental","pubTime":"2026-03-05 05:53","pubTimestamp":1772661200,"startTime":"0","endTime":"0","summary":"Impact BioMedical Inc. updated its previously disclosed merger and share exchange agreement with Dr Ashleys Limited and related parties, under which Dr Ashleys Limited would acquire Impact. Under the Feb. 27, 2026 amendment, Dr Ashleys Limited will issue 53,000 ordinary shares and an additional 75,000 ordinary shares to DSS, Inc. at closing, and confirmed that these DSS shares and 22,000 compensation shares for Impact CEO Frank D. Heuszel will be deducted from the share consideration otherwise issued to Dr Ashleys’ sole shareholder. The amendment also extended the outside date for completing the deal to July 1, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Biomedical Inc. published the original content used to generate th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL35dwq4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4087","BK4024","AEI","IBO","DSS","BK4563","BK4007"],"gpt_icon":0},{"id":"2604349901","title":"Universal Ibogaine Ties Delayed Audit to Restructuring and Planned Sale of Kelburn Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2604349901","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604349901?lang=en_us&edition=fundamental","pubTime":"2026-01-19 23:03","pubTimestamp":1768835016,"startTime":"0","endTime":"0","summary":"Universal Ibogaine Inc ( ($TSE:IBO) ) has provided an announcement. Universal Ibogaine Inc. has provided an update on its delayed year-end 2025 fin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/universal-ibogaine-ties-delayed-audit-to-restructuring-and-planned-sale-of-kelburn-facility?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/universal-ibogaine-ties-delayed-audit-to-restructuring-and-planned-sale-of-kelburn-facility?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4075","UVV","IBO"],"gpt_icon":0},{"id":"2601846897","title":"DSS, Inc. Reports Disposal of Impact Biomedical Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2601846897","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601846897?lang=en_us&edition=fundamental","pubTime":"2026-01-07 06:25","pubTimestamp":1767738346,"startTime":"0","endTime":"0","summary":"DSS, Inc., a significant beneficial owner, reported the disposal of common shares of Impact Biomedical Inc. . The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 06, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL2K7n2x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEI","BK4024","IBO","BK4087","DSS","BK4563","BK4007"],"gpt_icon":0},{"id":"2595710329","title":"Impact Biomedical Inc. Files Information Statement Outlining Authorized Corporate Actions","url":"https://stock-news.laohu8.com/highlight/detail?id=2595710329","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595710329?lang=en_us&edition=fundamental","pubTime":"2025-12-31 05:31","pubTimestamp":1767130277,"startTime":"0","endTime":"0","summary":"Impact BioMedical Inc. has announced that its shareholders have authorized key corporate actions as of December 30, 2025. These actions include amendments to the company’s Certificate of Incorporation and a reverse stock split, as referenced in recent company filings. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 30, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDLNc4vD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","IBO","AEI","BK4007","BK4024"],"gpt_icon":0},{"id":"2590544147","title":"Impact Biomedical Inc. Files Preliminary Information Statement Outlining Authorized Corporate Actions","url":"https://stock-news.laohu8.com/highlight/detail?id=2590544147","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590544147?lang=en_us&edition=fundamental","pubTime":"2025-12-12 06:12","pubTimestamp":1765491147,"startTime":"0","endTime":"0","summary":"Impact BioMedical Inc. shareholders have authorized key corporate actions, including a Reverse Stock Split and changes to Authorized Shares. These actions were approved on March 28, 2025. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 11, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL4jW1CS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","IBO","BK4007","AEI","BK4024"],"gpt_icon":0},{"id":"2586340411","title":"Universal Ibogaine Seeks Cease Trade Order Amid Financial Filing Delays","url":"https://stock-news.laohu8.com/highlight/detail?id=2586340411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586340411?lang=en_us&edition=fundamental","pubTime":"2025-11-26 06:05","pubTimestamp":1764108331,"startTime":"0","endTime":"0","summary":"Universal Ibogaine Inc ( ($TSE:IBO) ) has issued an announcement. Universal Ibogaine Inc. has applied for a management cease trade order (MCTO) due...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/universal-ibogaine-seeks-cease-trade-order-amid-financial-filing-delays?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/universal-ibogaine-seeks-cease-trade-order-amid-financial-filing-delays?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UVV","BK4007","BK4075","IBO"],"gpt_icon":0},{"id":"2581048866","title":"Impact Biomedical Inc. held annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2581048866","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581048866?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:15","pubTimestamp":1762463715,"startTime":"0","endTime":"0","summary":"Impact Biomedical Inc. held its annual meeting of stockholders on November 5, 2025. During the meeting, stockholders approved the election of Frank D. Heuszel, Elise Brownell, Melissa Sims, Castel Hibbert, David Keene, Christian Zimmerman, Jason Grady, and Chan Heng Fai Ambrose to the board of directors. The appointment of Grassi & Co. Certified Public Accountants, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was also ratified.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL3l9MFV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4024","BK4563","IBO","AEI","BK4007"],"gpt_icon":0},{"id":"2578072675","title":"Impact BioMedical Converts Preferred Stock to Common","url":"https://stock-news.laohu8.com/highlight/detail?id=2578072675","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578072675?lang=en_us&edition=fundamental","pubTime":"2025-10-28 04:35","pubTimestamp":1761597320,"startTime":"0","endTime":"0","summary":"Impact BioMedical, Inc. ( ($IBO) ) has shared an update. On October 30, 2023, Impact BioMedical, Inc. announced that DSS BioHealth Security, Inc. h...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/impact-biomedical-converts-preferred-stock-to-common?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/impact-biomedical-converts-preferred-stock-to-common?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","IBO"],"gpt_icon":0},{"id":"2569741867","title":"Universal Ibogaine Restructures Board Ahead of Clinical Trial Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2569741867","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569741867?lang=en_us&edition=fundamental","pubTime":"2025-09-24 05:42","pubTimestamp":1758663760,"startTime":"0","endTime":"0","summary":"Universal Ibogaine Inc ( ($TSE:IBO) ) has issued an announcement. Universal Ibogaine Inc. announced changes to its Board of Directors, with several...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/universal-ibogaine-restructures-board-ahead-of-clinical-trial-submission?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/universal-ibogaine-restructures-board-ahead-of-clinical-trial-submission?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBO","BK4007","UVV","BK4075"],"gpt_icon":0},{"id":"2569712650","title":"Impact Biomedical Inc. Announces Date for 2025 Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2569712650","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569712650?lang=en_us&edition=fundamental","pubTime":"2025-09-24 00:39","pubTimestamp":1758645556,"startTime":"0","endTime":"0","summary":"Impact BioMedical Inc. is set to hold its Annual Meeting of Stockholders on November 5, 2025, at their Houston location. The meeting will cover key resolutions, including the election of eight director nominees to serve until the next annual meeting, the ratification of Grassi & Co. Certified Public Accountants, P.C. as the Company's independent registered public accounting firm for the year ending December 31, 2025, and an advisory vote to approve executive compensation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nNDL5jrcsS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4563","AEI","BK4024","IBO"],"gpt_icon":0},{"id":"2567519868","title":"Universal Ibogaine Announces Key Outcomes from Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2567519868","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567519868?lang=en_us&edition=fundamental","pubTime":"2025-09-15 13:08","pubTimestamp":1757912901,"startTime":"0","endTime":"0","summary":"An update from Universal Ibogaine Inc ( ($TSE:IBO) ) is now available. Universal Ibogaine Inc. held its annual meeting of shareholders, where nine ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/universal-ibogaine-announces-key-outcomes-from-annual-shareholder-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/universal-ibogaine-announces-key-outcomes-from-annual-shareholder-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4075","BK4007","IBO","UVV"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}